Verily developed AI systems for digital pathology to reduce variability and maximize insights from biopsy tissues samples, according to a March 16 news release stated.
The collaboration aims to accomplish the following:
1. Enable Verily to validate its Gleason algorithms for prostate cancer by using Lumea’s platform and extensive database of pathology cases.
2. Integrate Verily’s algorithms into Lumea’s digital pathology platform. Pathologists will then have access to Verily’s AI to help identify and grade prostate cancer within their digital workflow.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
